Hydrogels for treating chronic wounds: a multi-pronged approach
水凝胶治疗慢性伤口:多管齐下
基本信息
- 批准号:10458596
- 负责人:
- 金额:$ 11.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AntioxidantsAttentionBindingBiologyBlood CirculationCancer cell lineCell ProliferationCharacteristicsChemicalsChemistryChronicCollaborationsCurcuminCystineDevelopmentDextransDiabetes MellitusDiabetic Foot UlcerEffectivenessEngineeringEnzymesEquilibriumEstersEvaluationExtracellular Matrix ProteinsExudateFibroblastsFoot UlcerHemostatic functionHydrogelsImpaired wound healingIn VitroInfectionInflammationInflammatoryKineticsLeg UlcerLinkMatrix Metalloproteinase InhibitorMatrix MetalloproteinasesMelatoninMetalsMethodsPeptide HydrolasesPeptidesPolymersProcessProductionPropertyReportingRiboseSilverSourceSystemic diseaseTherapeuticUniversitiesVaricose UlcerVascular DiseasesVascular Endothelial Growth FactorsVenousWaterZincabsorptionantimicrobialantimicrobial dressingbisphosphonatechelationchronic woundcollegecostcrosslinkdesigndiabeticexperiencehealingimprovedin vitro activitykeratinocytemicrobialnanoparticleporcine modelsuccesstherapeutic targetwound dressingwound healing
项目摘要
Project Summary/Abstract
Chronic leg and foot ulcers are considerably slow healing, lasting on average 12
to 13 months. They are commonly associated with systemic diseases and
conditions with impaired wound healing such as diabetes and vascular disease.
For example, diabetic leg ulcers are an example of a difficult to heal chronic
wound associated with diabetes and venous leg ulcers are a chronic wound
attributed to poor blood circulation. A hallmark of these chronic wounds is out of
balance inflammation caused by elevated levels of proteases, reactive oxidative
species (ROS) and instances of infection. Herein is proposed the design and
evaluation of hydrogels that target multiple aspects of a toxic inflammatory
process. These hydrogels are designed to counteract the high levels of ROS,
proteolytic activity and microbial infection present in chronic wounds. Hydrogels
comprised of polydopamine and curcumin will be developed to impart antioxidant
activity. Various strategies will be examined to counteract proteolytic matrix
metalloproteinase (MMP) activity. Zn2+ is responsible for the catalytic activity of
MMP and binding the metal is a well-established method to reduce its proteolytic
activity. Curcumin is an antioxidant with zinc chelation ability that has been
shown to reduce MMP activity and improve wound healing. We will synthesize
water-soluble degradable curcumin polymers for incorporation within hydrogels.
We propose these curcumin hydrogels will lower ROS and MMP activity.
Polydopamine will be used to synthesize silver nanoparticles (AgNPs) within the
hydrogels. AgNPs are well known for their antimicrobial properties but have also
been demonstrated to inhibit MMP. A third strategy is to chemically modify
hydrogels with bisphosphonate MMP inhibitors. On the other hand, agents that
promote cell proliferation are also shown to accelerate the healing process. We
will examine the effect of releasing 2-deoxy-D-ribose and melatonin, compounds
shown to promote proliferative processes while the hydrogel concurrently
suppresses inflammation.
Keywords. Hydrogels, chronic wounds, antimicrobial, wound healing, matrix
metalloproteinase
项目概要/摘要
慢性腿部和足部溃疡的愈合速度相当缓慢,平均持续 12 年
至 13 个月。它们通常与全身性疾病有关
伤口愈合受损的情况,例如糖尿病和血管疾病。
例如,糖尿病性腿部溃疡就是难以治愈的慢性溃疡的一个例子。
与糖尿病和腿部静脉溃疡相关的伤口是一种慢性伤口
归因于血液循环不良。这些慢性伤口的一个特点是
平衡蛋白酶、反应性氧化水平升高引起的炎症
物种(ROS)和感染实例。在此提出设计方案并
评估针对有毒炎症多个方面的水凝胶
过程。这些水凝胶旨在抵消高水平的活性氧,
慢性伤口中存在蛋白水解活性和微生物感染。水凝胶
将开发由聚多巴胺和姜黄素组成的抗氧化剂
活动。将研究各种策略来抵消蛋白水解基质
金属蛋白酶(MMP)活性。 Zn2+负责催化活性
MMP 和金属结合是减少其蛋白水解的行之有效的方法
活动。姜黄素是一种具有锌螯合能力的抗氧化剂,已被
经证明可降低 MMP 活性并改善伤口愈合。我们将综合
用于掺入水凝胶中的水溶性可降解姜黄素聚合物。
我们建议这些姜黄素水凝胶会降低 ROS 和 MMP 活性。
聚多巴胺将用于合成银纳米颗粒(AgNP)
水凝胶。 AgNP 以其抗菌特性而闻名,但也
已被证明具有抑制 MMP 的作用。第三种策略是化学修饰
具有双膦酸盐 MMP 抑制剂的水凝胶。另一方面,代理商
促进细胞增殖也被证明可以加速愈合过程。我们
将检查释放 2-脱氧-D-核糖和褪黑激素化合物的效果
显示出促进增殖过程,而水凝胶同时
抑制炎症。
关键词。水凝胶,慢性伤口,抗菌,伤口愈合,基质
金属蛋白酶
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Naphtali Andre O'Connor其他文献
Naphtali Andre O'Connor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Naphtali Andre O'Connor', 18)}}的其他基金
Hydrogels for treating chronic wounds: a multi-pronged approach
水凝胶治疗慢性伤口:多管齐下
- 批准号:
10237113 - 财政年份:2015
- 资助金额:
$ 11.08万 - 项目类别:
Hydrogels for treating chronic wounds: a multi-pronged approach
水凝胶治疗慢性伤口:多管齐下
- 批准号:
10671654 - 财政年份:2015
- 资助金额:
$ 11.08万 - 项目类别:
相似国自然基金
个体创业导向在数字化公司创业中的展现与效应研究:基于注意力基础观
- 批准号:72302074
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于数据自增强与多元注意力机制的结直肠图像息肉检测
- 批准号:82302310
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多头注意力机制的化学修饰siRNA药物活性预测研究
- 批准号:62302079
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于深度学习与注意力机制的棉蚜图像识别及监测模型研究
- 批准号:32360433
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于忆阻器的自注意力模型研究
- 批准号:62304254
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanistic Insights and Therapeutic Potential of the Glutaredoxin (Grx) System in the Lens
晶状体中谷氧还蛋白 (Grx) 系统的机理见解和治疗潜力
- 批准号:
10592813 - 财政年份:2023
- 资助金额:
$ 11.08万 - 项目类别:
Development of Protein Like Polymer Therapeutics for Modulating the Nrf2/Keap1 Protein Protein Interaction in Neurodegenerative Diseases
开发用于调节神经退行性疾病中 Nrf2/Keap1 蛋白相互作用的类蛋白聚合物疗法
- 批准号:
10537489 - 财政年份:2022
- 资助金额:
$ 11.08万 - 项目类别:
Novel carbon nanodots for modulation of OxLDL mediated inflammation and inhibition of atherosclerosis
用于调节 OxLDL 介导的炎症和抑制动脉粥样硬化的新型碳纳米点
- 批准号:
10046915 - 财政年份:2020
- 资助金额:
$ 11.08万 - 项目类别:
IDH1 is a novel therapeutic target in pancreatic cancer
IDH1是胰腺癌的新治疗靶点
- 批准号:
9911116 - 财政年份:2020
- 资助金额:
$ 11.08万 - 项目类别: